Yaya Drugs Target Muscle Makiya don Yarda Cutar Dama
Cibiyoyin Kula da Cututtuka da Cututtuka sun kiyasta cewa yawancin mutane 1.3 na Amirka suna fama da cututtukan cututtuka na rashin jiji (IBS) , wani ciwon gastrointestinal aikin da ke haifar da ciwon ciki da kuma canji a cikin halin daji.
Yayinda masu bincike basu gano ma'anar IBS ba, magunguna suna nufin kawar da bayyanar cutar (ciki har da ciwon ciki na ciki, damuwa, damuwa, cututtuka, da maƙarƙashiya).
Daga cikin kwayoyi daban-daban da ake amfani da ita don magance IBS, antispasmodics sun tabbatar da yadda ya dace wajen maganin bayyanar cututtuka ta hanyar ƙaddamarwa da kuma kwantar da tsokoki na ƙwayar narkewa. Tun da bayyanar cututtuka sun kasance mafi girma bayan mutum ya ci, ana amfani da kwayoyi kusan 30 zuwa 60 da minti kafin cin abinci.
Akwai hanyoyi daban-daban na antispasmodic da ake amfani da su don bi da IBS, ciki har da:
- Anticholinergics
- Mebeverine
- Peppermint mai
Anticholinergics
Anticholinergics wani nau'i ne na miyagun ƙwayoyi da aka tsara domin toshe magungunan acetylcholine. Wannan shi ne sinadarai da jiki ke samarwa wanda ke aiki akan tsarin jiki mai zaman kanta (wani ɓangare na tsarin mai juyayi wanda ke da alaka da ayyuka masu aiki). Ta hanyar tsayar da masu karɓar acetylcholine a cikin sashin kwayar cutar, kwayoyin halitta na iya rage yawan ƙwayar tsoka da tsofaffin ƙwayoyin tsoka.
Abin takaici, ƙwayar miyagun ƙwayoyi na iya rinjayar wasu sassan kwayoyin halitta , haifar da tasirin da ke tattare daga hangen nesa da maƙarƙashiya don rage urination da dizziness.
Saboda hadarin kamuwa da maƙarƙashiya, ana amfani da maganin maganin cututtuka a maganin cutar zafin jiki-IBS ( IBS-D ) maimakon maƙarƙashiya- IBS-C . Hanyoyin gyare-gyare na gastron kuma yana da tasiri.
Abubuwan da aka fi dacewa da su sun hada da:
- Hyoscyamine
Mebeverine
Mebeverine wani fasaha ne wanda yake aiki da kamuwa da kwayoyin halitta amma ba shi da sakamako na acetylcholine. An halayen halayen rashin tausayi a wasu, mafi yawa a cikin raƙuman ragu.
Mebeverine an ba da izini ga mutanen dake da IBS kuma suna samuwa a ƙarƙashin wasu alamu iri-iri kamar su Cofiyac, Duspamen, da Duspatalin.
Peppermint Oil
Man shafawa mai kari ne wanda ya ƙunshi menthol, wani abu wanda ya nuna yana da tasiri a kan ƙwayar tsoka.
Binciken nazarin karatun 2015 na Jami'ar California, San Diego ya kammala cewa mutanen da ke da alamun bayyanar cutar ta IBS sun kusan kusan sau uku kuma zasu iya samun taimako tare da man fetur da aka kwatanta da wadanda aka ba su wuribo.
Duk da yake an dauke lafiya don amfanin ɗan gajeren lokaci, an san man fetur mai sanyaya sanadiyar ƙwannafi (wani abin da zai iya kaucewa ta amfani da adadi mai ruɗi ). Tabbatar da tuntuɓi likitan ku kafin kuyi man fetur ko wani ƙarin kari.
Ya kamata a yi amfani da man shafawa da hankali a cikin mutanen da ke fama da ƙwannafi, ciwon hernia, hasara mai haɗari mai tsanani, ƙananan ƙumburi, ko ƙuntataccen ƙwayar bile.
Sauye-sauye na abinci
Baya ga magungunan antispasmodic, canje-canje na rage cin abinci zai iya inganta ingantacciyar cututtukan IBS.
Dangane da nau'in da kake fuskantar, zaka iya so:
- Ƙara yawan fiber na abinci ko amfani da ƙarin fiber don taimakawa ƙwarewar IBS ko zawo.
- Ƙara amfani da ruwa idan kun gaji.
- Guji maganin kafeyin. ( Shayi na Peppermint kyauta mai kyau ne.)
- Ka guje wa legumes don rage karfin jini.
- Abincin iyakance wanda ke dauke da lactose, fructose, ko FODMAPs (oligosaccharides mai yalwaci, disaccharides, monosaccharides, da polyols).
- Yi nazari na yau da kullum don kula da fure-fure mai kyau.
> Sources:
> Cibiyoyin Kula da Cututtuka da Cututtuka. "Ciwon annoba na IBD." Atlanta, Jojiya; sabunta Maris 31, 2015.
> Hyundai, A ;; Moyyadedi, P .; Lacy, B. et.al. "Kwalejin Amirka na Gastroenterology Monograph a kan Gudanar da Ciwo na Jijiyar Buka da Kwanciya" Amer J Gastroenterol. 2014; 109: S2-S26. DOI: 10.1038 / ajg.2014.187.
> Khanna, A; MacDonald, J; da Levesque, B. "Man shafawa don maganin cututtukan ciwon jijiyar ƙwayar cuta: nazari na yau da kullum da kuma bincike-bincike." J Jarin Gastroenterol. 2014; 48 (6): 505-12. DOI: 10.1097 / MCG.0b013e3182a88357.